International Trade Bulletin - Volume 1, Issue 13
Client Alert | 2 min read | 09.06.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- GMOs: The EU – U.S. controversy over the spread of unauthorized genetically modified rice fuels the already infected cross-Atlantic GMO debate
- EU Anti-Dumping: European Commission publicly acknowledges that it has started a comprehensive review of the way that the EU will apply anti-dumping measures in the future
- CUSTOMS CLASSIFICATION: After Doha: Practical Approaches for Cutting the Costs of Trade
- C-TPAT: C-TPAT Develops New Minimum Security Criteria for Foreign Manufacturers effective August 29, 2006
- CHINA: Bureau of Industry and Security Holds Regional Meetings with the Public to Explain New Proposed Export Control Rules for China
- MARKET ACCESS: With the collapse of the World Trade Organization's Doha Round and no clear timeline for its resurrection, member countries are expected to focus renewed attention on bilateral and regional free trade agreements (FTAs)
- SANCTIONS: The U.S. considers sanctions options on Iran
- PRIVACY: Commission Announces New Initiatives on EU-U.S. Passenger Data Transfer: More of the Same or Expanded Access to Such Data?
- IRAN: Focus on Iran – Singapore Airlines Joint Venture Sanctioned by OFAC
- JAPAN: Japanese Executives Arrested for Violation of Japan's Export Control Laws
Insights
Client Alert | 6 min read | 03.26.24
Starting next week, on April 1st, health care entities in California closing “material change transactions” will be required to notify California’s new Office of Health Care Affordability (“OHCA”) and potentially undergo an extensive review process prior to closing. The new review process will impact a broad range of providers, payers, delivery systems, and pharmacy benefit managers with either a current California footprint or a plan to expand into the California market. While health care service plans in California are already subject to an extensive transaction approval process by the Department of Managed Health Care, other health care entities in California have not been required to file notices of transactions historically, and so the notice requirement will have a significant impact on how health care entities need to structure and close deals in California, and the timing on which closing is permitted to occur.
Client Alert | 11 min read | 03.26.24
Client Alert | 6 min read | 03.21.24
Federal District Court Rules Corporate Transparency Act Unconstitutional
Client Alert | 2 min read | 03.21.24